EGFR-Targeting as a Biological Therapy: Understanding Nimotuzumab's Clinical Effects
about
Nimotuzumab in combination with radiotherapy in high grade glioma patients: a single institution experience.Nimotuzumab plus chemotherapy versus chemotherapy alone in advanced non-small-cell lung cancer: a multicenter, randomized, open-label Phase II studyTuning Sensitivity of CAR to EGFR Density Limits Recognition of Normal Tissue While Maintaining Potent Antitumor Activity.Pharmacokinetics and Biodistribution Study of 7A7 Anti-Mouse Epidermal Growth Factor Receptor Monoclonal Antibody and Its F(ab')(2) Fragment in an Immunocompetent Mouse ModelA view on EGFR-targeted therapies from the oncogene-addiction perspective.Lonely killers: effector cell- and complement-independent non-proapoptotic cytotoxic antibodies inducing membrane lesions.Nimotuzumab as a radiosensitizing agent in the treatment of high grade glioma: challenges and opportunities.Molecular targeting in combination with platinum-based chemoradiotherapy in head and neck cancer treatment.Nimotuzumab enhances radiation sensitivity of NSCLC H292 cells in vitro by blocking epidermal growth factor receptor nuclear translocation and inhibiting radiation-induced DNA damage repairPreclinical modeling of EGFR-specific antibody resistance: oncogenic and immune-associated escape mechanisms.
P2860
Q33631435-EA656E3C-0BEB-416B-B3CA-71F8756BE46FQ33779303-6D3BA6C9-46DB-49AD-B820-8A01968485EEQ36218880-3D166A86-80E3-4701-B09A-9C814B42668AQ36440219-204CEE49-926A-49C1-BEF6-0C5FA2D8407CQ36795486-789A2D7E-F56D-4212-9F80-85274C27331AQ37962075-C27A7CC9-BCFF-4649-A2DD-249F7A354D6AQ38127413-B95B65BB-0B0F-4C0F-B218-0CE81BA098DFQ38382066-5116A712-1C8A-4B67-B330-34A1420BE629Q39802972-E55A18A7-DA2C-4012-9C0D-AADE5D3A2E4CQ47704805-D825D50B-4889-42AE-ADD0-00BC7B5B3773
P2860
EGFR-Targeting as a Biological Therapy: Understanding Nimotuzumab's Clinical Effects
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
EGFR-Targeting as a Biological Therapy: Understanding Nimotuzumab's Clinical Effects
@en
EGFR-Targeting as a Biological Therapy: Understanding Nimotuzumab's Clinical Effects.
@nl
type
label
EGFR-Targeting as a Biological Therapy: Understanding Nimotuzumab's Clinical Effects
@en
EGFR-Targeting as a Biological Therapy: Understanding Nimotuzumab's Clinical Effects.
@nl
prefLabel
EGFR-Targeting as a Biological Therapy: Understanding Nimotuzumab's Clinical Effects
@en
EGFR-Targeting as a Biological Therapy: Understanding Nimotuzumab's Clinical Effects.
@nl
P2093
P2860
P356
P1433
P1476
EGFR-Targeting as a Biological Therapy: Understanding Nimotuzumab's Clinical Effects
@en
P2093
Greta Garrido
Rolando Perez
Tania Crombet
P2860
P304
P356
10.3390/CANCERS3022014
P577
2011-04-18T00:00:00Z